Health Condition 1: I130- Hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease
Conditions
Interventions
Control Intervention1: Amlodipine + telmisartan: 10 mg+ 40 mg Once daily for one month
Control Intervention2: Cilnidipine + Telmisartan: 5 mg + 40 mg once daily for 1 month
Sponsors
Sri Ramaswamy Memorial
Eligibility
Inclusion criteria
Inclusion criteria: male and female patients aged 18 years and above diagnosed with hypertension and diabetes mellitus patient with RAS inhibitor such as telmisartan use for more than six months
Exclusion criteria
Exclusion criteria: patients with severe hypertension greater than 180/95 and significant renal impairment CKD stage 2to5 were not included in the study malignant hypertension heart failure with in six months of cardiovascular events severe diabetes HbA1c above 9 were not included in the study pregnant and lactating women if the patient have low blood pressure or hypotensive below 110 they will be excluded if the proteinuria level also decreases the patient is excluded
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Creatinine level Hypertension Timepoint: 4th Month | — |
Secondary
| Measure | Time frame |
|---|---|
| Creatinine level & blood pressureTimepoint: 4th month | — |
Countries
India
Contacts
Public ContactDr S Sarumathy
SRM Medical College Hospital and Research Center
Outcome results
None listed